The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
BrainImmune: Trends in Neuroendocrine Immunology,
A few recent peer-reviewed or preliminary studies provide conflicting results about the efficacy of the interleukin-6 (IL-6…